Pricing
  1. JP-listed companies
  3. Financials
  4. Revenue growth (%)

【JP:7079】

Market cap
¥6.4B
P/E ratio
8.5x
WDB Coco provides outsourcing services to help pharmaceutical companies with drug safety monitoring, regulatory document preparation, and clinical research support.
SummaryFinancialsDividendsHistoryOwnershipWorkforce
Period EndRevenue growth (%) YoY (%)
Mar 31, 202515.9+23.33%
Mar 31, 202412.9+2.46%
Mar 31, 202312.6-69.01%
Mar 31, 202240.6+225.56%
Mar 31, 202112.5-55.87%
Mar 31, 202028.3+31.78%
Mar 31, 201921.5-25.28%
Mar 31, 201828.7+79.50%
Mar 31, 201716

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)